U.S. Markets close in 53 mins

Analysts Reiterate Incyte’s Target Price in March

Margaret Patrick
Analysts Reiterate Incyte’s Target Price in March

How Major Rare Disease Pharma Stocks Are Positioned in March(Continued from Prior Part)Analysts’ recommendations and target priceWall Street analysts expect a potential upside of 2.58% for Incyte (INCY) based on the stock’s closing price on